TAMPA, Fla., April 10, 2013 /PRNewswire-iReach/ -- The National Association of Specialty Pharmacy™ (NASP™) announced the appointment of James E. Smeeding, RPh, MBA, as the association's first Executive Director. The announcement was made during the NASP Inaugural Specialty Pharmacy Conference, which drew more than 500 participants representing all specialty pharmacy stakeholders.
"Specialty pharmacy is the fastest growing segment in pharmacy, and we need a strong leader to support NASP's commitment of creating a strong, unified voice for all stakeholders," Gary M. Cohen , BSPharm, RPh, NASP CEO and Co-Founder, said. "Jim is that leader. He is an experienced, skilled leader who is committed to our core values of improving patient outcomes and fostering a strong environment of collaboration."
Smeeding, who holds a pharmacy degree from the University of Buffalo and a Masters in Business Administration from the University of Texas, is a well-recognized and widely published leader in the pharmacy industry. He has experience in a variety of areas including hospital pharmacy, clinical services design, home infusion therapy, managed care services and disease management. Smeeding is the founder of the Center for Pharmacoeconomic Studies at the University of Texas, College of Pharmacy, where he has focused his research on pharmacoeconomics, systems integration and managed care.
"The NASP Board members unanimously felt Jim's previous track record of collaborative and inclusionary leadership in diverse industry roles over the years solidified our belief that he is the right individual to drive the mission of our organization," Burt Zweigenhaft , member of the NASP Board of Directors, said.
During his 40-year career, Smeeding has been instrumental in the development of companies servicing the pharmaceutical industry in
|SOURCE National Association of Specialty Pharmacy|
Copyright©2012 PR Newswire.
All rights reserved